| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|
| Change in fair value of warrant liabilities | 0 | 0 | 12,450 | |
| Total other income (expense), net | 2,834 | 3,003 | -10,014 | |
| Net loss | -14,209 | -16,869 | -28,656 | |
| Unrealized gain (loss) on short-term investments | 205 | -91 | 175 | |
| Comprehensive loss | -14,004 | -16,960 | -28,481 | |
| Earnings per share, basic | -0.33 | -0.39 | -0.93 | |
| Earnings per share, diluted | -0.33 | -0.39 | -0.93 | |
| Weighted average number of shares outstanding, basic | 43,634,006 | 43,390,652 | 30,714,769 | |
| Weighted average number of shares outstanding, diluted | 43,634,006 | 43,390,652 | 30,714,769 | |
Beta Bionics, Inc. (BBNX)
Beta Bionics, Inc. (BBNX)